| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 23, 2025 | Jan 27, 2025 | X4 Pharmaceuticals, Inc | CEO | Sell | 86.3 | +93,467 | 9.40% | ✓ | $34.7K |
| Nov 15, 2024 | Nov 19, 2024 | X4 Pharmaceuticals, Inc | CEO | Sell | 41.3 | -31,897 | -3.11% | ✓ | $12.6K |
| Oct 15, 2024 | Oct 16, 2024 | X4 Pharmaceuticals, Inc | CEO | Sell | 41.3 | -31,897 | -3.02% | ✓ | $17.9K |
| Oct 4, 2024 | Oct 8, 2024 | X4 Pharmaceuticals, Inc | CEO | Sell | 95.0 | +292,645 | 38.25% | ✓ | $131.5K |
| Mar 11, 2024 | Mar 11, 2024 | X4 Pharmaceuticals, Inc | CEO | Sell | 36.3 | -49,678 | -6.10% | ✓ | $43.9K |
| Feb 12, 2024 | Feb 12, 2024 | X4 Pharmaceuticals, Inc | CEO | Sell | 45.0 | -21,695 | -2.59% | ✓ | $21.9K |
| Nov 1, 2023 | Nov 3, 2023 | X4 Pharmaceuticals, Inc | CEO | Sell | 15.0 | -239,437 | -22.26% | ✓ | $181.6K |
| Jun 23, 2023 | Jun 26, 2023 | X4 Pharmaceuticals, Inc | CEO | Sell | 48.8 | -6,724 | -1.22% | ✓ | $12.9K |
| Jun 15, 2023 | Jun 16, 2023 | X4 Pharmaceuticals, Inc | CEO | Sell | 48.8 | -6,724 | -1.21% | ✓ | $15K |
| May 31, 2023 | May 31, 2023 | X4 Pharmaceuticals, Inc | CEO | Sell | 48.8 | -6,292 | -1.12% | ✓ | $12.3K |
| Mar 10, 2023 | Mar 13, 2023 | X4 Pharmaceuticals, Inc | CEO | Sell | 32.5 | -49,678 | -8.10% | ✓ | $41.7K |
| Feb 13, 2023 | Feb 15, 2023 | X4 Pharmaceuticals, Inc | CEO | Sell | 41.3 | -21,695 | -3.42% | ✓ | $20.2K |
| Jun 3, 2022 | Jun 6, 2022 | X4 Pharmaceuticals, Inc | CEO | Sell | 52.5 | -6,292 | -0.94% | ✓ | $7.6K |
| Aug 17, 2021 | Aug 19, 2021 | X4 Pharmaceuticals, Inc | CEO | Sell | 41.3 | -13,448 | -2.79% | ✓ | $68.6K |
| Jul 15, 2021 | Jul 16, 2021 | X4 Pharmaceuticals, Inc | CEO | Sell | 41.3 | -13,448 | -2.71% | ✓ | $77.7K |
| Jun 2, 2021 | Jun 2, 2021 | X4 Pharmaceuticals, Inc | CEO | Sell | 51.3 | -2,400 | -0.59% | ✓ | $22.8K |
| Jun 1, 2021 | Jun 2, 2021 | X4 Pharmaceuticals, Inc | CEO | Sell | 51.3 | -4,104 | -0.99% | ✓ | $38.6K |
| May 3, 2021 | May 4, 2021 | X4 Pharmaceuticals, Inc | CEO | Sell | 51.3 | -2,400 | -0.58% | ✓ | $20K |
| Apr 5, 2021 | Apr 7, 2021 | X4 Pharmaceuticals, Inc | CEO | Sell | 51.3 | -2,400 | -0.57% | ✓ | $22K |
| Mar 2, 2021 | Mar 2, 2021 | X4 Pharmaceuticals, Inc | CEO | Sell | 51.3 | -2,400 | -0.87% | ✓ | $23.4K |
| Feb 2, 2021 | Feb 3, 2021 | X4 Pharmaceuticals, Inc | CEO | Sell | 51.3 | -2,400 | -0.86% | ✓ | $18.9K |
| Jan 5, 2021 | Jan 6, 2021 | X4 Pharmaceuticals, Inc | CEO | Sell | 51.3 | -2,400 | -0.86% | ✓ | $16.8K |
| Dec 23, 2020 | Dec 28, 2020 | X4 Pharmaceuticals, Inc | CEO | Sell | 48.8 | -4,800 | -1.68% | ✓ | $33.6K |
| Oct 5, 2020 | Oct 6, 2020 | X4 Pharmaceuticals, Inc | CEO | Sell | 51.3 | -1,797 | -0.63% | ✓ | $12.6K |
| Oct 2, 2020 | Oct 5, 2020 | X4 Pharmaceuticals, Inc | CEO | Sell | 55.0 | -603 | -0.21% | ✓ | $4.2K |
| Sep 9, 2020 | Sep 10, 2020 | X4 Pharmaceuticals, Inc | CEO | Sell | 41.3 | -8,840 | -2.98% | ✓ | $71.1K |
| Sep 2, 2020 | Sep 3, 2020 | X4 Pharmaceuticals, Inc | CEO | Sell | 51.3 | -2,400 | -0.80% | ✓ | $19.2K |
| Aug 3, 2020 | Aug 4, 2020 | X4 Pharmaceuticals, Inc | CEO | Sell | 48.8 | -2,400 | -1.14% | ✓ | $17.9K |
| Jul 2, 2020 | Jul 6, 2020 | X4 Pharmaceuticals, Inc | CEO | Sell | 48.8 | -2,400 | -1.12% | ✓ | $21.7K |
| Jun 1, 2020 | Jun 3, 2020 | X4 Pharmaceuticals, Inc | CEO | Sell | 32.5 | -16,382 | -7.12% | ✓ | $143.9K |
| May 4, 2020 | May 5, 2020 | X4 Pharmaceuticals, Inc | CEO | Sell | 48.8 | -2,400 | -1.03% | ✓ | $21.4K |
| Apr 2, 2020 | Apr 3, 2020 | X4 Pharmaceuticals, Inc | CEO | Sell | 48.8 | -2,400 | -1.02% | ✓ | $20.2K |
| Mar 2, 2020 | Mar 3, 2020 | X4 Pharmaceuticals, Inc | CEO | Sell | 48.8 | -2,400 | -1.01% | ✓ | $25.5K |